← Azimuth Daily
Capturing data…
Capturing data…
SAT, 31 OCT · 72 ITEMS
"FDA begins enforcing clinical trial result transparency requirements" — Undark (science journalism) · Science & Medicine
Single sourceThe FDA has started actually enforcing long-standing legal requirements that sponsors publicly post summary results on , after years of limited oversight. In April 2026 the agency sent reminders or warnings to more than 2,200 sponsors and researchers with missing results, and Undark reports in late October 2026 that this marks the beginning of real enforcement. The practical effect is to reduce the ability of companies to quietly withhold negative or inconclusive trial findings from regulators, doctors, and patients.
The claim is well supported: it rests on the FDA's own April 2026 press release about warning more than 2,200 sponsors, plus FDA's published Transparency Roadmap and Undark's investigative reporting. The reporting sits close to the named primary source and the core numbers align across the agency statement and the article, though the headline's "begins enforcing" may compress a gradual ramp from warnings toward formal penalties.
This is genuinely current reporting: the article is dated 30 October 2026 and follows the FDA's April 2026 enforcement notices, not resurfaced older material.